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67 kDa laminin receptor (Rieger et al., 1997), which has
been identified as the receptor for the cellular prion pro-
tein (Gauczynski et al., 2001b) and demonstrated to be
required for PrPSc propagation in neuronal cells (Leucht
et al., 2003; for a review see Leucht and Weiss, 2002). 
One of the proposed models explaining the replication
of prions is the protein-only hypothesis (Alper et al., 1967;
Griffith, 1967; Prusiner, 1982), which states that a PrPSc
monomer interacts with a PrPc monomer to form a PrPSc/
PrPc heterodimer. PrPSc then converts PrPc to a PrPSc ho-
modimer by changing its secondary/tertiary structure.
Another model states that a nucleus or seed consisting of
PrPSc molecules incorporates PrPc monomers starting a
nucleation-dependent polymerization or crystal seed re-
action in which the PrPc monomers become converted to
PrPSc molecules (Lansbury and Caughey, 1995). Both
models result in an oligo-/multimerization process finally
leading to PrPSc aggregation.
PrP dimers (for review see Gauczynski et al., 2001a)
could play an essential role in this conversion process
and have been characterized as an intermediate state
during PrP-multimerization as analyzed by fluorescence
correlation spectroscopy (FCS) (Post et al., 1998; Jansen
et al., 2001). PrP dimers have been observed in N2a cells
and in scrapie-infected hamster brains (Priola et al.,
1995). Molecular modeling suggested the existence of
PrP/PrP dimers (Warwicker and Gane, 1996), which
might be involved in PrP interspecies transmission (War-
wicker, 1997). The existence of a monomer-dimer equilib-
rium of partially purified PrPc from cattle has been shown
(Meyer et al., 2000). Recently, crystallization of dimeric
PrP has been reported involving domain swapping of α-
helical structures (Knaus et al., 2001). Very recently, a sol-
uble and dimeric PrP fused to immunoglobulin Fcγ (PrP-
Fc2) was shown to delay PrPSc accumulation in mice
(Meier et al., 2003). Here we show by size exclusion chro-
matography that recombinant FLAG-tagged PrP from
hamster, human and cattle, purified to homogeneity from
the baculovirus system, elute predominantly as dimers
under native conditions. In the presence of DTT, the
monomeric PrP form was marginally increased suggest-
ing that disulfide bonds do not contribute to dimer for-
mation. We confirmed the PrP/PrP interaction in BHK
cells co-expressing oligohistidine and FLAG-tagged pri-
on proteins using recombinant Semliki Forest Virus
RNAs. Employing the yeast two-hybrid system, in which
the PrP/PrP interaction was further confirmed, we identi-
fied both the octarepeat region and the carboxy terminus
of the prion protein (PrP90-230) as PrP/PrP interaction
domains.
Defined mutations within the Prn-p gene lead to famil-
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Recently, crystallization of the prion protein in a
dimeric form was reported. Here we show that native
soluble homogenous FLAG-tagged prion proteins
from hamster, man and cattle expressed in the bac-
ulovirus system are predominantly dimeric. The
PrP/PrP interaction was confirmed in Semliki Forest
virus-RNA transfected BHK cells co-expressing
FLAG- and oligohistidine-tagged human PrP. The
yeast two-hybrid system identified the octarepeat re-
gion and the C-terminal structured domain (aa90-
aa230) of PrP as PrP/PrP interaction domains. Addi-
tional octarepeats identified in patients suffering
from fCJD reduced (wtPrP versus PrP+9OR) and
completely abolished (PrP+9OR versus PrP+9OR)
the PrP/PrP interaction in the yeast two-hybrid sys-
tem. In contrast, the Met/Val polymorphism (aa129),
the GSS mutation Pro102Leu and the FFI mutation
Asp178Asn did not affect PrP/PrP interactions. Proof
of interactions between human or sheep and bovine
PrP, and sheep and human PrP, as well as lack of in-
teractions between human or bovine PrP and ham-
ster PrP suggest that interspecies PrP interaction
studies in the yeast two-hybrid system may serve as
a rapid pre-assay to investigate species barriers in
prion diseases.
Keywords: Dimeric prion protein / Interspecies inter-
action /Mutations /Polymorphism/PrP-PrP interaction
domains /Semliki Forest virus /Yeast two-hybrid system.
Introduction
Prions are thought to be the infectious agents of trans-
missible spongiform encephalopathies (TSEs) (for review,
see Weissmann and Aguzzi, 1997; Prusiner et al., 1998;
Lasmézas and Weiss, 2000). Several binding partners for
the cellular form of the prion protein have been identified
(for review Gauczynski et al., 2001a), among them are
molecular chaperones such as Hsp60 (Edenhofer et al.,
1996), protein X (Kaneko et al., 1997) and the 37 kDa/
Intra- and Interspecies Interactions between Prion
Proteins and Effects of Mutations and Polymorphisms
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Fig. 1 Analysis of Recombinant FLAG::PrP from Hamster, Cattle and Man and FLAG::Hsp60 under Native and Denaturing Conditions.
Four hundred ng of purified FLAG::haPrP23-231 were analyzed by SDS-PAGE (12.5% PA) followed by silver staining of the gel (A) and
Western blotting (B) employing the monoclonal 3B5 antibody. (C) Six µg of non-denatured FLAG::haPrP23-231 were analyzed by size ex-
clusion chromatography (SEC) on a Superose 12 PC 3.2/30 column (Amersham Pharmacia). Marker proteins (LMW calibration kit) are in-
dicated. Six hundred ng of purified FLAG::bovPrP25-242 were analyzed by SDS-PAGE (12.5% PA) followed by silver staining of the gel
(D) and Western blotting (E) employing the 3 B5 antibody. (F) Four µg of non-denatured FLAG::bovPrP25-242 were analyzed by SEC as
described above. Four hundred ng of FLAG::huPrP23-230 were analyzed by SDS-PAGE (12.5% PA) followed by silver staining of the gel
(G) and Western blotting employing the JB007 antibody (H). (I) Eight µg of non-denatured FLAG::huPrP23-230 were analyzed by SEC in
the absence of DTT as described above. (J) Six µg of FLAG::huPrP23-230 were analyzed by SEC after denaturing with DTT. Three hun-
dred ng of purified FLAG::HSP60 were analyzed by SDS-PAGE (12.5% PA) followed by silver staining of the gel (K) and Western blotting
(L) employing an Hsp60-specific antibody. (M) Four µg of non-denatured FLAG::Hsp60 were analyzed by SEC as described above.
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ial Creutzfeldt-Jakob Disease (fCJD), Gerstmann-Sträus-
sler-Scheinker (GSS) Syndrome and fatal-familial insom-
nia (FFI) (for review see Lasmézas and Weiss, 2000). A se-
ries of mutations affect the octarepeat region of the prion
protein. fCJD patients encompassing two (Goldfarb
et al., 1993), four (Campbell et al., 1996), five (Goldfarb
et al., 1991), six (Owen et al., 1990), seven (Goldfarb et al.,
1991), eight (Goldfarb et al., 1991) and nine additional
octarepeats (Owen et al., 1992) have been described. All
these patients are heterozygous regarding these muta-
tions (Majtenyi et al., 2000). The mutation proline 102 to
leucine leads to GSS (Goldgaber et al., 1989). The poly-
morphism at position 129 of the human prion protein de-
termines whether an organism suffers from FFI (position
178 Asp to Asn, together with methionine at position
129), fCJD (position 178 Asp to Asn, together with valine
at position 129) or remains healthy (178 Asp and 129 Met
or 129 Val) (Tateishi et al., 1995, and references therein).
Each patient suffering from nvCJD investigated so far
was homozygous for methionine at position 129 (Zeidler
et al., 1997; Hill et al., 1999). We investigated whether rel-
evant mutations and polymorphisms within the Prn-p
gene affect the PrP/PrP interaction behavior. Mutated
PrP proteins with alterations in the octarepeat region, the
first PrP/PrP binding domain, encompassing two, five
and nine additional octarepeats reduced the PrP/PrP in-
teraction when tested against wild-type PrP, and com-
pletely abolished the PrP/PrP interaction when PrP+5OR
or PrP+9OR were tested against each other. Point muta-
tions located in the second PrP/PrP interaction domain
(90-230), however, leading to amino acid substitutions at
positions 102 (proline to leucine), 129 (methionine to va-
line) and 178 (aspartate to asparagine), respectively, did
not influence the PrP/PrP interaction behavior as as-
sayed in the yeast two-hybrid system, suggesting a path-
ogenic mechanism different from that induced by the ad-
ditional octarepeats. Finally, we investigated interspecies
interactions of prion proteins of different species includ-
ing man, cattle, sheep and hamsters in the yeast two-hy-
brid system, and suggest that this system might be a
useful and rapid pre-assay to investigate species barriers
in prion diseases.
Results
Recombinant Human, Bovine and Hamster PrP Are
Dimeric under Native Conditions
FLAG-tagged human, bovine and hamster PrP were syn-
thesized in Sf9 cells infected with recombinant bac-
uloviruses and purified to homogeneity by anti-FLAG an-
tibody chromatography. The homogeneous PrP from
hamster, cattle and man revealed a molecular mass of
approx. 27 kDa under denaturing and reducing condi-
tions on an SDS-polyacrylamide gel (Figure 1A, D and G)
and was recognized by PrP-specific antibodies (Fig-
ure 1B, E and H). Under native conditions, however,
FLAG-tagged hamster, bovine and human PrP revealed
molecular masses of 53, 54 and 53 kDa, respectively, and
to a minor extent molecular masses of 24, 25 and 24 kDa,
respectively, as determined by size exclusion chromato-
graphy (Figure 1C, F and I), demonstrating that PrP from
these three species are predominantly dimeric under na-
tive conditions. The measured values are close to the val-
ues derived from the individual amino acid sequences,
which are 23.9, 24.5 and 23.7 kDa, respectively, for ham-
ster, bovine and human PrP. In the presence of DTT, the
proportion of the monomeric form of human PrP was in-
creased from 1.9 to 6.6%, whereas the proportion of the
dimeric form decreased from 98.1 to 93.4% (Figure 1J),
suggesting that intermolecular disulfide bonds do not, or
only marginally, contribute to PrP dimer formation. Analy-
sis of the FLAG-tagged prion proteins of all three species
on native PA gels in the absence and presence of β-mer-
captoethanol resulted in no difference in the migration
pattern (data not shown), confirming the result from the
size exclusion chromatography that intermolecular disul-
fide bonds do not, or only marginally, contribute to PrP
dimer formation. The FLAG-tagged heat shock protein
Hsp60 synthesized in the baculovirus system (Figure 1K,
L) was monomeric under native conditions as measured
by size exclusion chromatography (Figure 1M), demon-
strating that the FLAG tag is not responsible for the
dimerization behavior of FLAG- tagged PrP. The strong
peak representing a molecule of 40 kDa is a breakdown
product of the FLAG- tagged Hsp60, which is also visible
in the Western blot (Figure 1L), whereas the small peak at
a molecular mass of 13.7 kDa reveals a breakdown prod-
uct that is too small in amount to be visible by Western
blotting (Figure 1L).
The FLAG-tagged dimeric prion proteins from hamster,
man and cattle revealed proteinase K (pK) sensitivity at
4 µg/ml pK incubated for 60 min at 37°C (data not shown)
suggesting that all three recombinant proteins are non-
infectious. Recombinant monomeric prion proteins from
hamster, man and cattle (purchased from Prionics) also
showed total pK sensitivity under the same experimental
conditions (data not shown), demonstrating that mono-
meric and dimeric prion proteins do not differ with re-
spect to proteinase K sensitivity.
PrP/PrP Interaction in Recombinant Semliki Forest
Virus (SFV) RNA Transfected BHK Cells Co-
Expressing Oligohistidine- and FLAG-Tagged PrP
In order to confirm the PrP/PrP interaction in a eukaryot-
ic system, we chose BHK cells co-expressing highly gly-
cosylated oligohistidine- and FLAG-tagged human prion
proteins after transfection with recombinant Semliki For-
est Virus RNAs. The protein/protein interaction was in-
vestigated by pull-down assays with immobilized oligo-
histidine-tagged PrP on nickel columns followed by the
detection of the interacting FLAG-tagged protein with an
anti-FLAG antibody. After co-expression of PrP227-
oligohistidine-228 – 253 and PrP227-FLAG-228 – 253,
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the non-, mono-, and diglycosylated forms of FLAG-
tagged PrP were detectable (Figure 2, lane 3), demon-
strating the interaction of both prion proteins in BHK
cells. Expression of FLAG-tagged PrP alone resulted in a
weak background binding of the mono- and diglycosylat-
ed forms of the prion protein to the nickel column due to
the histidine-rich octarepeat region of PrP (lane 4). Here
the sugars seem to have an effect on the residual nickel
binding since the non-glycosylated band does not inter-
act with the nickel column. As positive controls the PrP
interacting proteins 37 kDa laminin receptor precursor
(LRP; Rieger et al., 1997; Gauczynski et al., 2001b; Hundt
et al., 2001; Leucht et al., 2003; Simoneau et al., 2003)
and Hsp60 (Edenhofer et al., 1996) (lane 1), both tagged
with FLAG, were used. Both proteins bound to oligohisti-
dine-tagged PrP (lane 1 and 2, respectively). As a nega-
tive control PrP did not interact with LRPdelBD::FLAG
lacking the direct PrP binding domain expressed in CHO-
S-745 cells (Hundt et al., 2001; Figure 4, panel K).
PrP/PrP Interaction and Identification of PrP/PrP
Interaction Domains by Yeast Two-Hybrid Analyses 
Co-expression of human PrP tagged to the highly soluble
GST in bait and prey positions of the yeast two-hybrid
system (Gyuris et al., 1993) resulted in a strong interac-
tion of both proteins (Figure 3, row 3), confirming the
PrP/PrP interaction observed in recombinant SFV-RNA
transfected BHK cells. GST did not interact with itself or
with GST::PrPc (Figure 3, rows 1 and 2, respectively).
Next, we investigated which regions of the prion protein
are involved in the PrP/PrP interaction process. The high-
ly flexible unstructured octarepeat region of PrP, also
known as the proline/glycine-rich region (Donne et al.,
1997; Riek et al., 1997), which has been shown to bind
copper in vivo (Brown et al., 1997), consists of five (six in
cattle) repeats of a stretch of eight amino acids (PHGGG-
WGQ). Co-expression of the human PrP octarepeat do-
main in both positions of the yeast two-hybrid system re-
sulted in a strong interaction between the two truncated
PrP proteins (Figure 3, row 5). The ultimate amino-termi-
nus of PrP (aa23-50), however, failed to interact with itself
(Figure 3, row 6), demonstrating that this region of PrP is
not involved in the PrP/PrP interaction. Deletion of the
octarepeat domain resulted in a weaker interaction signal
(Figure 3, row 4), suggesting the existence of a second
PrP/PrP interaction domain. Co-expression of PrP90-
230 in both bait and prey positions of the yeast two-hy-
brid system indeed resulted in a strong interaction signal
(Figure 3, row 7). In summary, these data demonstrate
that the octarepeat region and PrP90-230 contribute to
PrP/PrP interactions.
Additional Octarepeats Located in the First PrP/PrP
Interaction Domain Impede PrP/PrP Interaction
Since the octarepeat region represents a PrP/PrP inter-
action domain, we investigated whether additional
octarepeats identified in familial CJD patients might influ-
ence the PrP interaction behavior. When human PrP en-
compassing two (Figure 4, row 7), five (row 8) and nine
(row 9) additional octarepeats was expressed in bait ver-
sus wild-type PrP in the prey position of the yeast two-
hybrid system, the PrP/PrP interaction was only slightly
diminished. This situation mimics the heterozygous state
in all patients investigated so far expressing the mutated
PrP on one allele and the wild-type PrP from the other al-
lele. However, when mutated human prion proteins en-
compassing two (Figure 4, row 4), five (row 5) and nine
(row 6) additional octarepeats were co-expressed in both
positions of the yeast two-hybrid system, reflecting a
thus far hypothetical case of a patient homozygous for
this Prn-p mutation, the PrP/PrP interaction was strongly
reduced with two additional octarepeats (row 4) and
completely abolished with five (row 5) and nine (row 6)
additional octarepeats.
The Mutations Pro102Leu (GSS), Asp178Asn (FFI)
and the Polymorphism Met129Val Do Not Influence
the PrP/PrP Interaction
We investigated the polymorphism Met-Val at position
129, the mutation Pro-Leu at position 102 and the muta-
tion Asp-Asn at position 178 (polymorphism aa129 me-
thionine) of the human prion protein with respect to their
influence on the PrP/PrP interaction behavior. Neither
this polymorphism nor the mutation at position 102 ex-
pressed as bait versus wild-type PrP as prey (Figure 5,
lanes 6 and 4), or both expressed in both bait and prey
positions (Figure 5, lanes 7 and 5), reflecting the het-
erozygous and homozygous states, respectively, affect-
ed the PrP/PrP interaction behavior. In addition, the FFI-
794 C. Hundt et al.
Fig. 2 Analysis of PrP/PrP Interactions in BHK Cells Co-Trans-
fected with Recombinant Semliki Forest Virus RNAs.
Extracts of total protein from BHK cells either non-transfected
(lane 5), transfected with SVF1-huPrP1-227FLAG228-253
(lane 4) or co-transfected with SVF1-huPrP1-227FLAG228-253
and SVF1-huPrP1-227HIS228-253 (lane 3), SVF1-huPrP1-
227HIS228-253 and SFV1-LRP::FLAG (lane 2) or SVF1-huPrP1-
227HIS228-253 and SFV1-Hsp60::FLAG (lane 1) were harvested
48 h post-transfection, purified by IMAC, analyzed on a 12%
PAA-SDS gel, blotted and developed with the monoclonal anti-
FLAG antibody (M2).
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Fig. 3 Identification of PrP/PrP Interaction Domains in the Yeast Two-Hybrid System (S. cerevisiae).
Yeast cells containing the reporter plasmid pSH18-34 were co-transformed with prey plasmids pJG-GST (rows 1 and 2), pJG-
GST::PrP23-230 (row 3), pJG-GST::PrP∆GP (row 4), pJG-GST::GP52-93 (row 5), pJG-GST::PrP23-50 (row 6) and pJG-GST::PrP90-230
(row 7) as well as the bait plasmids pSH-GST (row 1), pSH-GST::huPrP23-230 (rows 2 and 3), pSH-GST::PrP∆GP (row 4), pSH-
GST::PrP52-93 (row 5), pSH-GST::PrP23-50 (row 6) and pSH-GST::PrP90-230 (row 7). Each of three transformants were resuspended
in TE, dotted on X-gal-supplemented plates and incubated at 30°C for 3 days (β-galactosidase assay).
Fig. 4 Influence of Additional Octarepeats on the PrP/PrP In-
teraction Behavior.
Yeast cells encompassing the reporter plasmid pSH18-34 were
co-transformed with prey plasmids pJG-GST (rows 1 and 2),
pJG-GST::PrP23-230 (rows 3, 7, 8 and 9), pJG-GST::PrP+2OR
(row 4), pJG-GST::PrP+5OR (row 5), pJG-GST::PrP+9OR (row 6)
as well as the bait plasmids pSH-GST (row 1), pSH-GST::PrP23-
230 (rows 2 and 3), pSH-GST::PrP+2OR (rows 4 and 7), pSH-
GST::PrP+5OR (rows 5 and 8), pSH-GST::PrP+9OR (rows 6 and
9) (β-galactosidase assay).
Fig. 5 Influence of the GSS Mutation P102L, the Polymor-
phism M129V and the Mutation D178N on the PrP/PrP Interac-
tion Behavior Analyzed in the Yeast Two-Hybrid System.
Yeast cells containing the reporter plasmid pSH18-34 were co-
transformed with prey plasmids pJG-GST (rows 1 and 2), pJG-
GST::PrP23-230 (rows 3, 4, 6 and 8), pJG-GST::PrP-P102L
(row 5), pJG-GST::PrP-M129V (row 7), and pJG-GST::PrP+9OR
(row 9) as well as the bait plasmids pSH-GST (row 1), pSH-
GST::PrP23-230 (rows 2 and 3), pSH-GST::PrP-P102L (rows 4
and 5), pSH-GST::PrP-M129V (rows 6 and 7), pSH-GST::PrP-
D178N (row 8) and pSH-GST::PrP+9OR (row 9) (β-galactosidase
assay).
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related mutation 178 Asp to Asn (aa129 methionine) did
not influence the PrP/PrP interaction behavior when ex-
pressed in bait versus wild-type PrP in the prey position
(heterozygous case; Figure 5, lane 8). We conclude that
both mutations together with the polymorphism, which
all reside within PrP90-230, have no influence on the
PrP/PrP interaction behavior. Thus PrP dimers can be
formed in all familial CJD (including cases due to addi-
tional octarepeats since they are exclusively heterozy-
gous), GSS and FFI cases investigated.
Interaction of Prion Proteins of Different Species in
the Yeast Two-Hybrid System
In order to investigate whether prion proteins of different
species interact with each other, we verified the interac-
tion between prion proteins of different species in the
yeast two-hybrid system. As already observed with hu-
man PrP (Figure 3), bovine PrP (Figure 6, row 5), ovine
PrP (AQ) (Figure 6, row 8) and hamster PrP (Figure 6,
row12) also interact with each other. Regarding inter-
species interactions, human PrP interacts with bovine
PrP (Figure 6, row 6) and ovine PrP (AQ) (Figure 6,
row 10), but not with hamster PrP (Figure 6, row 13).
Bovine PrP shows an interaction with ovine PrP (Figure 6,
row 9) but no interaction with hamster PrP (Figure 6,
row 14). For specificity controls we verified that no PrP
species binds to GST (Figure 6, rows 2, 4, 7 and 11). 
Discussion
According to the protein-only hypothesis (Prusiner, 1982)
and the nucleation-dependent polymerization model
(Lansbury and Caughey, 1995), PrPc converts into PrPSc
by either a PrPSc monomer (Prusiner, 1982) or a PrPSc
seed (Lansbury and Caughey, 1995). Recently, PrP
dimers have been characterized as an intermediate state
during the PrP-oligo- and multimerization processes an-
alyzed by fluorescence correlation spectroscopy (FCS)
(Post et al., 1998). PrP dimers consisting of α-helical PrP
monomers were only stable for less than a minute but PrP
dimers consisting of mainly β-sheeted monomers have
been found to be stable for about 10 minutes (Post et al.,
1998). Recently, a soluble and stable α-helical intermedi-
ate of recombinant hamster PrP (90-231) was identified
by size exclusion chromatography and chemical cross-
linking (Jansen et al., 2001). PrP dimers have also been
described in uninfected mouse neuroblastoma cells (Pri-
ola et al., 1995) with an approximate molecular mass of
60 kDa. Similar 60 kDa PrP molecules were identified in
scrapie-infected hamster brains but not in uninfected
brains (Priola et al., 1995). These authors suggested that
the 60 kDa dimeric PrP might contribute to the conver-
sion of protease-sensitive to protease K-resistant PrP.
Very recently, we generated a covalently-linked dimer of
the prion protein (Riley et al., 2002). This highly glycosy-
lated dimer is transported to the plasma membrane and
reveals proteinase K sensitivity, suggesting that the dimer
lacks endogenous infectivity.
Dimerization of Recombinant Prion Proteins from
Human, Cattle and Hamster under Native Conditions
A monomer/dimer equilibrium of partially-purified PrPc
from cattle has been described previously (Meyer et al.,
2000). More recently, crystallization of the dimeric recom-
binant PrP has been reported, involving domain swap-
ping of the C-terminal helix 3 and rearrangement of the
disulfide bond (Knaus et al., 2001). We have shown here
that recombinant full-length FLAG-tagged PrP from hu-
man, cattle or hamster purified from insect cells infected
with recombinant baculoviruses exist predominantly in
dimeric form under native conditions. Our recombinant
PrP was purified under native conditions from the medi-
um of insect cells infected with recombinant baculovirus-
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Fig. 6 Interaction Analysis of PrP of Different Species in the
Yeast Two-Hybrid System.
The bait plasmids pSH-GST (row 1), pSH-GST::huPrP23-230
(rows 2 and 3), pSH-GST::bovPrP25-242 (rows 4 – 6), pSH-
GST::shPrP25-234 (AQ) (rows 7 – 10) and pSH-GST::haPrP
(rows 11 – 14) were co-transformed with the reporter plasmid
pSH18-34 and the prey plasmids pJG-GST (rows 1, 2, 4, 7 and
11), pJG-GST::huPrP23-230 (rows 3, 6, 10 and 13), pJG-
GST::bovPrP25-242 (rows 5, 9 and 14) and pJG-GST::shPrP25-
234 (AQ) (row 8) (β-galactosidase assay).
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es. Addition of DTT increases the monomeric form of PrP
slightly, suggesting that disulfide bridges do not, or only
marginally, participate in PrP dimer formation. We can
exclude that the FLAG tag used for purification induces
dimerization of our recombinant protein, since FLAG-
tagged Hsp60 appeared to be solely monomeric.
All recombinant dimeric prion proteins of the three dif-
ferent species revealed proteinase K sensitivity, suggest-
ing that these proteins lack infectivity. Since monomeric
prion proteins from the same species (purchased from
Prionics) showed the same proteinase K sensitivity, we
conclude that monomeric and dimeric prion proteins do
not differ with respect to proteinase K sensitivity and in-
fectivity.
PrP/PrP Interactions in BHK Cells Transfected with
Recombinant SFV-RNAs
In order to prove the PrP/PrP interaction in highly devel-
oped eukaryotic cells, we transiently co-expressed
FLAG-tagged and oligohistidine-tagged PrP in BHK cells
using the Semliki Forest Virus system. Employing pull
down assays, we demonstrated the interaction of these
highly glycosylated prion proteins in an evolutionarily
highly developed cell system.
PrP/PrP Interactions and Identification of PrP/PrP
Interaction Domains
Direct PrP/PrP interactions have not been reported so far.
We employed the yeast two-hybrid system as a powerful
tool for the detection of protein/protein interactions
(Gyuris et al., 1993). The yeast two-hybrid system is also
useful for the identification of interaction domains of cy-
tosolic (Lopez et al., 2001) and membrane-associated
proteins (Bowman et al., 2000). Expression of PrP in bait
and prey positions of the yeast two-hybrid system result-
ed in a direct interaction of both proteins. Expression of
PrP truncations and deletion mutants in the same system
identified the octarepeat region as one PrP/PrP interac-
tion domain with a copper binding capacity in vivo
(Brown et al., 1997) and an intrinsic superoxide dismu-
tase activity (Brown, 1999). This flexible unstructured re-
gion of PrP (Donne et al., 1997; Riek et al., 1997) might be
important for the physiological function of the prion pro-
tein and might be involved in the PrPc/PrPSc conversion
process. The internalization process of the prion protein
is governed by metal binding to octarepeats (Sumudhu
et al., 2001). Very recently, the octarepeat region has
been identified as an indirect interaction domain for the
binding of the prion protein to its 37 kDa/67 kDa laminin
receptor mediated by cell surface heparan sulfate pro-
teoglycans (HSPGs), which act as co-factors/co-recep-
tors for the PrP binding/internalization process (Hundt
et al., 2001). Biosensor and enzyme-linked immunosor-
bent assay methodologies identified, in addition to the
octarepeat region of the prion protein (aa53-93), regions
stretching from aa23-52 and aa110-128 of the prion pro-
tein as heparin and heparan sulfate binding sites (Warner
et al., 2002). Interestingly, the interaction of the octare-
peat-spanning peptide (aa53-93) with heparin was en-
hanced by Cu(II) ions. A peptide encompassing the
octarepeat region was able to inhibit the binding of full-
length PrP to heparin, which suggests a direct role in he-
parin recognition within the intact prion protein (Warner
et al., 2002). 
Deletion of the octarepeat region resulted in a weaker
PrP/PrP interaction in the yeast two-hybrid system, sug-
gesting that a second PrP/PrP interaction domain within
the carboxy-terminal part of PrP may exist. Co-expres-
sion of PrP90-230 in both positions of the yeast two-hy-
brid system resulted in a direct interaction between both
truncated PrP molecules, demonstrating that the car-
boxy-terminus of PrP (PrP90-230) represents a second
PrP/PrP interaction domain. Since DTT affects PrP
dimerization only marginally (Figure 1J), we conclude that
intermolecular disulfide bridges do not, or only marginal-
ly, contribute to PrP dimer formation.
Influence of Additional Octarepeats in the PrP/PrP
Interaction Processes
Additional octarepeats have been identified in patients
suffering from familial CJD (Owen et al., 1990, 1992;
Goldfarb et al., 1991, 1993; Campbell et al., 1996). PrP
encompassing nine additional octarepeats associated
with familial CJD failed to undergo Cu2 +-mediated endo-
cytosis, suggesting that neurodegeneration may arise
from the ablation of internalization due to mutation of the
octarepeats (Sumudhu et al., 2001). Since these muta-
tions affect the octarepeat region as one PrP/PrP interac-
tion domain, we investigated whether these mutations
may influence the PrP/PrP interaction behavior. Expres-
sion of mutated PrP encompassing two, five and nine ad-
ditional octarepeats in the bait position versus wild-type
PrP in the prey position of the yeast two-hybrid system
slightly diminished the PrP/PrP interaction process. This
situation mimics heterozygous CJD patients with the mu-
tated Prn-p gene on one allele and the wild-type Prn-p on
the other (Majtenyi et al., 2000). Expression of mutated
PrP with five and nine additional octarepeats in both po-
sitions of the yeast two-hybrid system resulted in total in-
hibition of the PrP/PrP interaction, reflecting to our
knowledge a hypothetical homozygous CJD patient ex-
pressing this mutated PrP on both alleles of the Prn-p
gene. Our results suggest that PrP/PrP interactions take
place in all heterozygous CJD patients expressing addi-
tional octarepeats.
Transgenic mice expressing a mutant PrP encompass-
ing nine additional octarepeat copies exhibit a slowly
progressive neurological disorder characterized clinically
by ataxia and neuropathologically by cerebellar atrophy
and granule cell loss, gliosis, and PrP deposition that is
most prominent in the cerebellum and hippocampus
(Chiesa et al., 1998). Moreover, these mice produce PrP
that is more pK resistant than normal PrPc (though it
seems not to represent bona fide PrPSc), which accumu-
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lates concomitant with massive apoptosis of granule
cells in the cerebellum (Chiesa et al., 2000). These fea-
tures are more pronounced in homozygous [Tg(PG14+/+)]
than in heterozygous [Tg(PG14+/–)] mice (Chiesa et al.,
2000). These data, together with the observation that ad-
ditional octarepeats cause familial CJD in humans,
demonstrate that the additional nine octarepeats indeed
have a pathogenic effect. Very recently, we detected that
recombinant huPrP encompassing nine additional
octarepeats synthesized in the Semliki Forest Virus (SFV)
system revealed proteinase K resistance (Gauczynski
et al., 2002), suggesting that this mutant prion protein
might encompass endogenous infectivity. Non-dimer-
ized PrPc may not be able to fulfill its normal physiologi-
cal function and be abnormally processed. The recent
finding that nine additional octarepeats in PrP prevent the
protein from copper-mediated endocytosis (Brown et al.,
1997) provides one explanation for the neurodegenera-
tion observed in patients encompassing this mutation.
Whether the wild-type prion protein appears monomeric
or dimeric at the cell surface remains to be investigated. 
Moreover, a free N-terminus might render the non-
dimerized prion protein more prone to misfolding and
probably to conversion into PrPSc. We hypothesize that
the availability of the second carboxy-terminal PrP/PrP
interaction domain is then required for PrPSc to convert
more free PrPc molecules, resulting in prion propagation.
This requirement is fulfilled in heterozygous cases of fa-
milial CJD, were PrP/PrP interaction does still occur as
shown in the yeast two-hybrid analysis (PrP+9OR versus
wild-type PrP).
Hence, we speculate that PrP/PrP interaction via the
octarepeat binding domain may be important for the nor-
mal physiological function of PrP and for the stabilization
of PrPc/PrPc dimers. In the heterozygous case, PrPc/PrPc
interaction is reduced but PrPc/PrPSc interaction does still
occur, most likely via the second PrP/PrP interaction do-
main (PrP90-230). We speculate that this binding domain
might be important for the PrPc/PrPSc conversion
process, since PrP90-230 dimers have been identified
within the PrP oligomerization/multimerization process
analyzed by FCS (Post et al., 1998; Jansen et al., 2001).
Influence of TSE Relevant Mutations and
Polymorphisms on the PrP/PrP Interaction Behavior
Defined mutations within the human Prn-p gene, such as
the Leu102Pro mutation or the Asp178Asn mutation,
lead to GSS and FFI, respectively (for a review see Las-
mézas and Weiss, 2000). The polymorphism at position
129 Met/Val influences the susceptibility of humans to-
ward FFI, fCJD and nvCJD. Interestingly enough, all pa-
tients suffering from nvCJD investigated so far are ho-
mozygous for methionine at this position (Zeidler, 1997;
Hill et al., 1999). All these mutations and the polymor-
phism either expressed in both positions or in bait versus
wild-type PrP in the prey position of the yeast two-hybrid
system did not affect the PrP/PrP interaction process.
These findings are in good agreement with the assump-
tion that only mutations such as E200K affecting helix 3
of the prion protein may interfere with PrP dimer forma-
tion via the structured region of PrP.
In summary, PrP/PrP interactions occur via the octare-
peat region and the carboxy-terminal region from aa90 to
230 in the case of human PrP. From these findings we as-
sume that interactions of the prion protein might occur in
all patients suffering from GSS, FFI, fCJD and nvCJD and
might be important for the PrPc/PrPSc conversion
process. Here, PrP/PrP interaction inhibitors may act as
powerful tools in the therapy of TSEs. Also in the case of
familial CJD caused by additional octarepeats, PrP/PrP
interaction may still occur most likely via the PrP90-230
interaction domain. Blockage of this interaction may also
result in an interference of the PrPSc replication process.
In a homozygous case, in which PrP/PrP interaction
might be completely blocked by five or nine additional
octarepeats (here also the interaction via the second PrP
binding domain PrP90-230 is impeded probably due to
sterical reasons), the monomeric PrP might not be
processed normally and may not fulfill its normal physio-
logical functions, leading to the syndromes observed in
transgenic mice expressing a mutated PrP with nine ad-
ditional octarepeats. Such a PrP seems to aggregate in a
more pK-resistant form, but prion replication has not
been proved (Chiesa et al., 1998, 2000). Very recently, we
proved that the human PrP mutants D178N/M129 lead-
ing to FFI and huPrP+9OR leading to fCJD revealed pro-
teinase K resistance, suggesting that they might be infec-
tious and might lead to PrP replication (Gauczynski et al.,
2002).
Heterodimerization of Prion Proteins of Different
Species
Investigating the interspecies interaction of prion pro-
teins, we expressed prion proteins of different species in
bait and prey positions of the yeast two-hybrid system.
Bovine PrP interacted with human PrP, but hamster PrP
failed to interact with bovine and human PrP (Table 1).
These data are in fairly good accord with interspecies
transmissions of prions. Indeed there is now convincing
evidence from interspecies transmission studies in ani-
mals (Lasmézas et al., 1996, 2001; Bruce et al., 1997) and
transgenic mice (Hill et al., 1997; Scott et al., 1999) that
cattle BSE prions have been transmitted to humans
(Table 1). Hamsters have not been successfully inoculat-
ed with bovine PrP (Bradley and Wilesmith, 1993), and
Creutzfeldt-Jakob disease was only serially transmitted
to Syrian hamsters via guinea pigs (Manuelidis et al.,
1978; Table 1). In the latter case, incubation times varied
depending on the CJD strain used. Our yeast two-hybrid
data further demonstrate an interaction between ovine
PrP (AQ) and bovine or human PrP. There are no trans-
mission data between sheep and humans (Table 1). How-
ever, the ovine scrapie agent has been transmitted to
transgenic mice expressing bovine PrP (Scott et al.,
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2000). Cattle infected with the scrapie agent either intrac-
erebrally (Cutlip et al., 1994) or intramuscularly, subcuta-
neously or orally (Clark et al., 1995) developed TSEs
(Table 1). Although epidemiological data suggest that the
ovine scrapie agent is hardly transmissible to humans, a
sheep-human transmission that we suggest from our
yeast two-hybrid data cannot be excluded. Employing
the in vitro conversion system (Caughey et al., 1995), in-
ter-conversion studies have been performed that further
confirm our interspecies interaction results obtained from
the yeast two-hybrid system: both, bovine PrPBSE and
ovine PrPSc (AQ) converted human PrPsen, although only
to a minimal extent, into a proteinase K-resistant form
(Raymond et al., 2000; Table 1). Sheep PrPsen (AQ) was
converted by PrPBSE into the pK resistant state (Raymond
et al., 1997; Table 1), whereas hamster PrPsen was not
converted by bovine PrPBSE (Raymond et al., 1997;
Table 1). In summary, our results of interspecies PrP in-
teractions in the yeast two-hybrid system are in good
harmony with transmission data obtained from trans-
genic and non-transgenic animals and with inter-conver-
sion results obtained from the in vitro conversion assay.
Therefore, we suggest that the yeast two-hybrid system
acts as a fast pre-assay system to investigate species
barriers in prion diseases.
Additional experiments including powerful PrP/PrP
dimerization inhibitors might further clarify the role of PrP
dimers in the replication mechanism of prions and the
physiological function of PrP.
Materials and Methods
Recombinant Proteins Generated in the Baculovirus
System
FLAG::haPrP23-231 has been generated as described previous-
ly (Rieger et al., 1997). cDNAs encoding huPrP23-230, and
bovPrP25-242 obtained from H. Kretzschmar (Munich, Ger-
many) and M. Shinagawa (Obihiro, Japan), respectively, were
generated by PCR and cloned into the transfer vector pFLAG-
BAC (Rieger et al., 1997) via BamHI (5’) and EcoRI (3’). The
Hsp60 encoding cDNA was amplified from the vector pEt3a in-
troducing BamHI (5’) and PstI (3’) restriction sites and cloned
into the vector pFLAG-BAC (Rieger et al., 1997). Recombinant
viruses were generated by co-transfection of the transfer vec-
tors with linearized viral DNA according to the manufacturer’s in-
structions (Baculogold; Pharmingen). Recombinant FLAG::
haPrP23-231, FLAG::huPrP23-230 and FLAG::bovPrP25-242
were expressed in baculovirus-infected Sf9 cells and purified to
homogeneity as described previously for FLAG-tagged haPrP
(Rieger et al., 1997).
Recombinant pSFV Plasmid Construction
Construction of SFV1-LRP::FLAG was described by Gauczyns-
ki et al. (2001b). Construction of pSFV1-Hsp60::FLAG. The
Hsp60 encoding cDNA was amplified by PCR from pEt3a intro-
ducing a BamHI and a XmaI restriction site at the 5’ and 3’ ends.
The 1755 bp fragment, which contains the Kozak sequence and
AUG at the 5’ end and a FLAG tag encoding sequence at the 3’
end was cloned into the SFV expression plasmid pSFV1 (Lilje-
strom and Garoff, 1991) via BamHI/XmaI restriction sites, result-
ing in pSFV1-Hsp60::FLAG. Construction of pSFV1-huPrP1-
227FLAG228-253 and pSFV1-huPrP1-227HIS228-253. The
insertion of a FLAG or a HIS tag encoding sequence between
codons 227 and 228 of the human PrP sequence was done by
PCR using the pSFV1-huPrP1-253 plasmid DNA as a template.
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Table 1 Comparison of Interspecies Interactions in the Yeast Two-Hybrid System with Interconversion Studies Performed by the in
vitro Conversion Systema and Transmission Studies in Transgenic and Non-Transgenic Animals.
PrP species PrP species Interspecies inter- Interconversions by Interspecies Interspecies 
actions by the yeast in vitro conversion transmission transmission 
two-hybrid system assaysa in transgenic mice in animals
Human Cattle + +b +c +d
Sheep Cattle + +e +f +g
Sheep Human + +b n.d. n.d.
Hamster Human – n.d. n.d. via guinea pigsh
Hamster Cattle – –e n.d. –i
‘+’ Interaction in the yeast two-hybrid system, interconversion by in vitro conversion assays, transmission in transgenic mice and non-
transgenic animals.
‘–’ No interaction in the yeast two-hybrid system, no interconversion, no transmission in animals.
n.d.: not determined.
aAccording to Caughey et al. (1995).
bRaymond et al. (2000).
cHill et al. (1997); Scott et al. (1999).
dLink between nvCJD and BSE demonstrated in macaques inoculated with PrPBSE (Lasmézas et al., 1996) and mice inoculated with
PrPBSE/PrPnvCJD (Bruce et al., 1997; Lasmezas et al., 2001).
eRaymond et al. (1997).
fScott et al. (2000).
gCutlip et al. (1994); Clark et al. (1995).
hManuelidis et al. (1978).
iBradley and Wilesmith (1993).
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A 135 bp fragment (insertion of the FLAG encoding sequence)
and a 129 bp fragment (insertion of the HIS encoding sequence),
which both encode the carboxy-terminus of huPrP, were ampli-
fied, introducing a StuI restriction site (endogenous site within
codons 223 – 225) at the 5’-end, the tag-encoding sequence be-
tween codons 227 and 228, as well as a BamHI site at the
3’-end. Both fragments were digested with StuI and BamHI and
ligated via the StuI restriction site to a 707 bp fragment encoding
the amino terminal part of huPrP from pSFV1-huPrP1-253
digested with BamHI and StuI. The ligated DNA fragments were
cloned into the expression plasmid pSFV1 via the BamHI restric-
tion sites resulting in pSFV1-huPrP1-227FLAG228-253 and
pSFV1-huPrP1-227HIS228-253. The correct constructions of
pSFV1-Hsp60::FLAG, pSFV1-huPrP1-227FLAG228-253 and
pSFV1-huPrP1-227HIS228-253 was confirmed by dideoxyse-
quencing. The plasmid DNA pSFV1-huPrP1-253 was described
elsewhere (Krasemann et al., 1996).
Preparation of SFV-mRNA in vitro
The recombinant plasmid DNAs pSFV1-huPrP1-227FLAG228-
253, pSFV1-huPrP1-227HIS228-253, and pSFV1-LRP::FLAG
were linearized with SpeI, the pSFV1-Hsp60::FLAG plasmid DNA
was cut with SapI (due to the internal SpeI restriction site within
the encoding sequence). The linearized plasmid DNAs were puri-
fied by phenol-chloroform extraction followed by ethanol precip-
itation. Transcriptions were carried out in a total volume of 50 µl
containing 1.5 µg linearized plasmid DNA, 10× SP6 transcription
buffer (0.4 M Tris-HCl, pH 8.0 at 20°C; 60 mM MgCl2; 100 mM
dithiothreitol; 20 mM spermidine), 1 mM of each ATP, CTP and
UTP, 500 µM of GTP, 1 mM of m7G(5’)ppp(5’)G, 50 units of RNasin
and 50 units of SP6 RNA polymerase and incubated for 2 h at
37°C. The correct length of the transcripts was proven by
agarose gel electrophoresis. RNA was stored at – 20°C.
Mammalian Cell Culture, Transfection and Co-Transfection
Studies with the Semliki Forest Virus (SFV) System
Baby hamster kidney cells (BHK-21 C13; ATCC CCL 10) were
cultured in Dulbecco’s modified Eagle’s medium supplemented
with 10% heat-inactivated fetal calf serum (FCS), 2 mM L-gluta-
mine, 100 µg/ml penicillin and 100 µg/ml streptomycin at 37°C
with 5% CO2. Transfection and co-transfection were carried out
by electroporation, where RNA was added directly from the in
vitro transcription reaction to the BHK cells. BHK cells with a
confluency of ~80% were rinsed with PBS (without MgCl2 and
CaCl2), trypsinized, washed again and finally re-suspended in
PBS to a density of 107 cells/ml. The total amount of transcribed
RNA was mixed with 0.8 ml cells and the mixture transferred to
a 0.4 cm cuvette. For co-transfection, both RNAs were added in
proportion 1:1 to the cells. Electroporation was carried out at
room temperature by two consecutive pulses at 850 V/25 µF us-
ing a Bio-Rad Gene Pulser. The time constant after each pulse
should be 0.4 to 0.5. The total volume of the electroporated cells
(8×106) was plated on 10 cm dishes containing 15 ml of com-
plete growth medium. The cells were incubated at 37°C with 5%
CO2 for 48 h. 
Pull-Down Assays
BHK cells co-expressing huPrP-HIS and FLAG-tagged proteins
such as huPrP::FLAG, LRP::FLAG, Hsp60::FLAG (SFV-system)
were harvested 48 h post transfection, washed once with PBS
and then lysed in PBS supplemented with 0.1% Triton-X-100 
at 4°C. The crude lysates were obtained by centrifugation at
20 200 g at 4°C for 15 min and purified by the batch method
using a Chelating Sepharose Fast Flow gel (Pharmacia Biotech)
charged with nickel. The histidine-tagged protein (huPrP-HIS)
was bound overnight by rotating at 4°C, washed four times
with PBS and eluted overnight by competition with PBS con-
taining 500 mM imidazole at 4°C. In order to investigate the in-
teraction between huPrP-HIS and the co-expressed FLAG-
tagged proteins (mentioned above) the eluates were analyzed
by Western blotting using the monoclonal anti-FLAG antibody
M2 (Sigma).
Yeast Two-Hybrid Analysis
Construction of plasmid pSH2-1-GST::huPrP23-230 was de-
scribed previously (Rieger et al., 1997). The cloning procedure of
all other human PrP constructs into the vector pSH2-1 was analo-
gous. The GST::huPrP23-230 encoding cDNA was excised from
pSH2-1-GST::huPrP23-230 and subcloned into pJG4-5 via EcoRI
and SalI. All other constructs were cloned into the vector pJG4-5
in the same way. The construct pSH2-1-GST::huPrP∆GP lacking
the octarepeat region aa 51-91 was generated by Kunkel mutage-
nesis (Kunkel, 1985). The constructs pSH2-1-GST::huPrPGP
(aa52-93), pSH2-1-GST::huPrP23-50 and pSH2-1-GST::
huPrP90-230 were amplified by PCR using oligodesoxyribonu-
cleotides coding for the different PrP-sequences flanked by
BamHI (5’) and SalI (3’) restriction sites. The fragments were
cloned via BamHI and SalI restriction sites into the vector pSH2-1.
The construct pSH2-1-GST::huPrP23-230+9OR was subcloned
from the vector pSFV1-huPrP+9OR (gift from Dr. S. Krasemann).
The constructs pSH2-1-GST::huPrP23-230+2OR and pSH2-1-
GST::huPrP23-230+5OR were generated by BstXI restriction of
the construct with additional 9 octarepeats and ligation of the re-
striction products with different lengths. This resulted in the inser-
tion of 2 and 5 additional octarepeats. The constructs pSH2-1-
GST::huPrP23-230P102L and pSH2-1-GST::huPrPM129V were
cloned by Kunkel mutagenesis. The construct pSH2-1-GST::
huPrPD178N (FFI) was subcloned from the plasmid pSFV1-
huPrPD178N (FFI) (Krasemann et al., 1996), which was a gener-
ous gift from Dr. S. Krasemann. The construct pSH2-1-GST::
bovPrP25-242 was subcloned from the plasmid pSFV1-bov
PrP via BamHI (Krasemann et al., 1996) and SalI. The construct
pSH2-1-GST::haPrP23-231 was subcloned from the plasmid
pGEX-2T::haPrP23-231 (Weiss et al., 1995) via BamHI and SalI.
The construct pSH2-1-GST::shPrP25-234 (A/Q) was subcloned
from ovine DNA (generous gift from W. Goldmann) via BamHI and
SalI. All PrP constructs were confirmed by sequencing. The differ-
ent bait plasmids, the prey plasmid pJG4-5-LRP and the reporter
plasmid pSH18-34 (lacZ) were co-transformed into EGY48 cells
and transformants were tested in β-galactosidase assays.
Proteinase K Digestion Assay
One hundred ng each of recombinant huPrP, bovPrP and haPrP
synthesized in E.coli (Prionics) and 100 ng each of FLAG::
huPrP23-230, FLAG::bovPrP25-242 and FLAG::haPrP23-
231 synthesized in the baculovirus system purified by anti-FLAG
antibody chromatography have been digested with a final con-
centration of 0, 1, 4, 8 and 20 µg/ml proteinase K in 50 mM Tris-
HCl pH 7.4, 1 mM CaCl2. After 1 h at 37°C, reactions were termi-
nated with 1 mM pefabloc and analyzed by Western blotting
employing the JB007 antibody.
SDS-PAGE, Native PA Gel Electrophoresis and Western
Blotting
Proteins were analyzed by SDS-PAGE under reducing condi-
tions (in the presence of 5 mM β-mercaptoethanol) followed by
800 C. Hundt et al.
Bereitgestellt von | Universitaetsbibliothek der LMU Muenchen
Angemeldet | 129.187.254.47
Heruntergeladen am | 18.11.13 12:09
silver staining of the gel or by Western blotting. Detection was
performed by chemiluminescence. For analysis under native
conditions, proteins were separated on native polyacrylamide
gels (12% PAA bottom, 8% PAA middle and 6% PAA top). PAA
was diluted in 1× TBE buffer. Protein samples were diluted in
40% glycine (diluted in water). Electrophoresis was performed at
25 mA for 1 h. Protein bands were electroblotted onto nitrocellu-
lose and detection was performed employing the 3B5 antibody. 
Size Exclusion Chromatography (SEC)
The Superose 12 PC 3.2/30 column (Amersham Pharmacia) was
calibrated with the LMW calibration kit using the buffer 20 mM
HEPES pH 7.4. 2.5 µg (25 µl) each of the homogeneous FLAG-
tagged PrP from human, bovine and cattle expressed in the bac-
ulovirus system were loaded. The proteins were eluted with the
same buffer at a flow rate of 30 µl/min and detected with a UV-M
II monitor at 280 nm. For denaturation FLAG::huPrP23-230 was
incubated with 100 mM DTT, 95°C for 15 minutes.
Antibodies and Proteins
The monoclonal anti-PrP antibody 3B5 was kindly provided by
G. Hunsmann, Göttingen, Germany, the polyclonal antibody
JB007 was a kind gift of Corinne Ida Lasmézas, Fontenay-aux-
Roses, France. Anti-FLAG antibody M2 was purchased from
Sigma. Secondary anti-mouse IgG-POD conjugated was pro-
vided by Sigma. Monomeric recombinant prion protein from
man, cattle and hamster were obtained from Prionics, Switzer-
land.
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